These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14508524)

  • 1. Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl.
    Harnois T; Constantin B; Rioux A; Grenioux E; Kitzis A; Bourmeyster N
    Oncogene; 2003 Sep; 22(41):6445-54. PubMed ID: 14508524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs.
    Daubon T; Chasseriau J; El Ali A; Rivet J; Kitzis A; Constantin B; Bourmeyster N
    Oncogene; 2008 Apr; 27(19):2673-85. PubMed ID: 18059343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.
    Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF
    Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells.
    Daubon T; Rochelle T; Bourmeyster N; Génot E
    Eur J Cell Biol; 2012; 91(11-12):978-87. PubMed ID: 22717125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two bcr/abl fusion gene products, P210bcr/abl and P190bcr/abl, are equally sensitive to the protein tyrosine phosphatase of mature granulocytes.
    Nishimura J; Okamura J; Shibata K; Takahira H; Yufu Y; Kato S; Hirata J; Umemura T; Nawata H
    Int J Hematol; 1991 Dec; 54(6):471-8. PubMed ID: 1793829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.
    Yi SJ; Lee HT; Groffen J; Heisterkamp N
    Int J Mol Med; 2008 Oct; 22(4):453-8. PubMed ID: 18813851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in tyrosine phosphorylated proteins between cells expressing P210bcr/abl and P190bcr/abl.
    Nishimura J; Shibata K; Sadamura S; Takahira H; Hirata J; Umemura T; Nawata H; Okamura J
    Int J Hematol; 1992 Jun; 55(3):227-33. PubMed ID: 1379843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr, and 3BP-1.
    Zhang B; Zheng Y
    Biochemistry; 1998 Apr; 37(15):5249-57. PubMed ID: 9548756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sequential analysis of p210- and p190-bcr-abl by RT-PCR after allogeneic bone marrow transplantation for p210/p190-bcr-abl double positive acute lymphoblastic leukemia].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Motomura S; Kodama F; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Feb; 42(2):89-93. PubMed ID: 11280922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase CKIIalpha interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cells.
    Mishra S; Reichert A; Cunnick J; Senadheera D; Hemmeryckx B; Heisterkamp N; Groffen J
    Oncogene; 2003 Nov; 22(51):8255-62. PubMed ID: 14614449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
    Wang L; Zhu K; Zheng Y
    Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Bcr/Abl with C3G, an exchange factor for the small GTPase Rap1, through the adapter protein Crkl.
    Cho YJ; Hemmeryckx B; Groffen J; Heisterkamp N
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1276-83. PubMed ID: 15982636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression.
    Geay JF; Buet D; Zhang Y; Foudi A; Jarrier P; Berthebaud M; Turhan AG; Vainchenker W; Louache F
    Cancer Res; 2005 Apr; 65(7):2676-83. PubMed ID: 15805265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon.
    Liu J; Campbell M; Guo JQ; Lu D; Xian YM; Andersson BS; Arlinghaus RB
    Oncogene; 1993 Jan; 8(1):101-9. PubMed ID: 8423987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR and its mutants, the reciprocal t(9;22)-associated ABL/BCR fusion proteins, differentially regulate the cytoskeleton and cell motility.
    Zheng X; Güller S; Beissert T; Puccetti E; Ruthardt M
    BMC Cancer; 2006 Nov; 6():262. PubMed ID: 17090304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to imatinib of bcr/abl p190 lymphoblastic leukemia cells.
    Mishra S; Zhang B; Cunnick JM; Heisterkamp N; Groffen J
    Cancer Res; 2006 May; 66(10):5387-93. PubMed ID: 16707466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
    Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H
    Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of pleckstrin homology domain of the Bcr-Abl protein: analysis of protein-protein and protein-lipid interactions.
    Miroshnychenko D; Dubrovska A; Maliuta S; Telegeev G; Aspenström P
    Exp Cell Res; 2010 Feb; 316(4):530-42. PubMed ID: 19944685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression.
    Tala I; Chen R; Hu T; Fitzpatrick ER; Williams DA; Whitehead IP
    Leukemia; 2013 Apr; 27(5):1080-9. PubMed ID: 23207522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analyses of the Wrch atypical Rho family GTPases.
    Shutes A; Berzat AC; Chenette EJ; Cox AD; Der CJ
    Methods Enzymol; 2006; 406():11-26. PubMed ID: 16472646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.